BR112012027279A2 - composições de emulsão farmacêutica com baixo teor de óleo que compreendem progestogênio - Google Patents
composições de emulsão farmacêutica com baixo teor de óleo que compreendem progestogênioInfo
- Publication number
- BR112012027279A2 BR112012027279A2 BR112012027279A BR112012027279A BR112012027279A2 BR 112012027279 A2 BR112012027279 A2 BR 112012027279A2 BR 112012027279 A BR112012027279 A BR 112012027279A BR 112012027279 A BR112012027279 A BR 112012027279A BR 112012027279 A2 BR112012027279 A2 BR 112012027279A2
- Authority
- BR
- Brazil
- Prior art keywords
- progestogen
- low oil
- emulsion compositions
- pharmaceutical emulsion
- oil pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32795910P | 2010-04-26 | 2010-04-26 | |
| US32796310P | 2010-04-26 | 2010-04-26 | |
| US32796810P | 2010-04-26 | 2010-04-26 | |
| EP10161029 | 2010-04-26 | ||
| EP10161032 | 2010-04-26 | ||
| EP10161034 | 2010-04-26 | ||
| US201061424407P | 2010-12-17 | 2010-12-17 | |
| US201061424402P | 2010-12-17 | 2010-12-17 | |
| US201061424411P | 2010-12-17 | 2010-12-17 | |
| EP10195766.0 | 2010-12-17 | ||
| EP10195760.3 | 2010-12-17 | ||
| EP10195766 | 2010-12-17 | ||
| US61/424,402 | 2010-12-17 | ||
| EP10195764 | 2010-12-17 | ||
| US61/424,407 | 2010-12-17 | ||
| EP10195760 | 2010-12-17 | ||
| EP10195764.5 | 2010-12-17 | ||
| PCT/EP2011/056548 WO2011134944A2 (en) | 2010-04-26 | 2011-04-26 | Low-oil pharmaceutical emulsion compositions comprising progestogen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112012027279A2 true BR112012027279A2 (pt) | 2018-05-15 |
| BR112012027279B1 BR112012027279B1 (pt) | 2020-12-29 |
Family
ID=44001967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012027279-9A BR112012027279B1 (pt) | 2010-04-26 | 2011-04-26 | composições de emulsão farmacêutica com baixo teor de óleo que compreendem progestogênio |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US8476252B2 (pt) |
| EP (4) | EP2857042B1 (pt) |
| JP (1) | JP5886273B2 (pt) |
| KR (1) | KR101822680B1 (pt) |
| CN (2) | CN102946864A (pt) |
| AR (1) | AR081542A1 (pt) |
| AU (1) | AU2011246527B2 (pt) |
| BR (1) | BR112012027279B1 (pt) |
| CA (2) | CA2797253C (pt) |
| EA (1) | EA022460B1 (pt) |
| ES (4) | ES2514690T3 (pt) |
| GE (1) | GEP20166457B (pt) |
| HK (1) | HK1181998A1 (pt) |
| IL (2) | IL222710A (pt) |
| MX (1) | MX2012012491A (pt) |
| MY (1) | MY156858A (pt) |
| NZ (1) | NZ603176A (pt) |
| PL (1) | PL2563335T3 (pt) |
| PT (1) | PT2563335E (pt) |
| SG (1) | SG185025A1 (pt) |
| TW (1) | TW201138782A (pt) |
| WO (2) | WO2011134944A2 (pt) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201138782A (en) | 2010-04-26 | 2011-11-16 | Besins Healthcare Lu Sarl | Low-oil pharmaceutical emulsion compositions comprising progestogen |
| PT2782584T (pt) | 2011-11-23 | 2021-09-02 | Therapeuticsmd Inc | Preparações e terapias de substituição para hormonoterapias naturais combinadas |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| EP2819650A1 (en) | 2012-02-29 | 2015-01-07 | B. Braun Melsungen AG | Hormone containing emulsion comprising krill phospholipids |
| TW201334808A (zh) * | 2012-02-29 | 2013-09-01 | Braun Melsungen Ag | 含有荷爾蒙之包含磷蝦磷脂質的乳劑 |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| WO2014145303A1 (en) * | 2013-03-15 | 2014-09-18 | Pharmagenesis, Inc. | Intravenous emulsions of triptolide as immunomodulators and anticancer agents i |
| US10801070B2 (en) | 2013-11-25 | 2020-10-13 | The Broad Institute, Inc. | Compositions and methods for diagnosing, evaluating and treating cancer |
| US11725237B2 (en) | 2013-12-05 | 2023-08-15 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
| EP4052724A1 (en) * | 2013-12-06 | 2022-09-07 | The Broad Institute Inc. | Formulations for neoplasia vaccines |
| KR20160101073A (ko) | 2013-12-20 | 2016-08-24 | 더 브로드 인스티튜트, 인코퍼레이티드 | 신생항원 백신과의 병용 요법 |
| RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
| BR112016029338A2 (pt) | 2014-07-29 | 2017-08-22 | Therapeuticsmd Inc | creme transdérmico |
| WO2016100975A1 (en) | 2014-12-19 | 2016-06-23 | Massachsetts Institute Ot Technology | Molecular biomarkers for cancer immunotherapy |
| WO2016100977A1 (en) | 2014-12-19 | 2016-06-23 | The Broad Institute Inc. | Methods for profiling the t-cel- receptor repertoire |
| JP6814148B2 (ja) * | 2015-03-31 | 2021-01-13 | フレゼニウス カービ ドイチュラント ゲーエムベーハー | 非経口投与用のエマルション |
| CN116196401A (zh) | 2015-05-20 | 2023-06-02 | 博德研究所 | 共有的新抗原 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| CN106074383B (zh) * | 2016-07-27 | 2019-03-08 | 武汉科福新药有限责任公司 | 孕激素药物脂微球注射液及其制备方法 |
| US20180207177A1 (en) * | 2017-01-23 | 2018-07-26 | Government Of The United States As Represented By The Secretary Of The Air Force | TREATMENT OF TRIPLE NEGATIVE BREAST CANCER UTILIZING ANDROST-5-ENE-3b,17b-DIOL (b-AED), ANDROST-5-ENE-3b,7b,17b-TRIOL (b-AET) AND ESTRADIOL (E2) |
| US11549149B2 (en) | 2017-01-24 | 2023-01-10 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
| KR20210102936A (ko) * | 2018-12-10 | 2021-08-20 | 헤일로 사이언스 엘엘씨 | 안정적인 마취제 제제 및 관련 복용량 형태 |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
| EP3878434A1 (en) * | 2020-03-12 | 2021-09-15 | Lipoid GmbH | Sunflower phospholipid composition containing phosphatidylcholine |
| US20230098327A1 (en) * | 2021-08-30 | 2023-03-30 | Premier Nutrition Company, Llc | Sleep-inducing beverage composition, its method of production and the method of use |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60258110A (ja) | 1984-06-05 | 1985-12-20 | Daigo Eiyou Kagaku Kk | 静脈注射可能なプロゲステロン乳化注射液 |
| IL89856A (en) | 1989-04-05 | 1993-05-13 | Yissum Res Dev Co | Medical emulsions for liphophilic drugs containing a medium-chain triglyceride oil as a carrier |
| US5364632A (en) * | 1989-04-05 | 1994-11-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Medicinal emulsions |
| SE9301171D0 (sv) * | 1993-04-07 | 1993-04-07 | Ab Astra | Pharmaceutical composition containing lipophilic drugs |
| SE9403389D0 (sv) | 1994-10-06 | 1994-10-06 | Astra Ab | Pharmaceutical composition containing derivattves of sex hormones |
| WO2001007086A1 (en) * | 1999-07-22 | 2001-02-01 | Aventis Pharmaceuticals, Inc. | Preserved pharmaceutical formulations |
| US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
| US6327968B1 (en) | 2000-03-17 | 2001-12-11 | Pizza Hut, Inc. | System and method for producing par-baked pizza crusts |
| EP1488785A1 (de) | 2003-06-18 | 2004-12-22 | B. Braun Melsungen Ag | Ölemulsion zur postnatalen Hormonsubstitution |
| WO2005105040A2 (en) | 2004-04-26 | 2005-11-10 | Micelle Products, Inc. | Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications |
| DE602004022523D1 (de) | 2004-07-02 | 2009-09-24 | Novagali Pharma Sa | Verwendung von Emulsionen zur intra- und periocularen Injection |
| US7473687B2 (en) | 2005-03-24 | 2009-01-06 | Emory University | Methods for the treatment of a traumatic central nervous system injury |
| ES2428313T3 (es) | 2005-03-24 | 2013-11-07 | Emory University | Métodos para el tratamiento de lesiones del sistema nervioso central mediante un protocolo de administración decreciente |
| KR20140093764A (ko) * | 2006-02-09 | 2014-07-28 | 산텐 세이야꾸 가부시키가이샤 | 안정한 제제와 그 제조 및 사용 방법 |
| CN101152186B (zh) * | 2007-09-05 | 2011-07-06 | 杭州平和安康医药科技有限公司 | ***注射液及其制备方法 |
| TW201138782A (en) | 2010-04-26 | 2011-11-16 | Besins Healthcare Lu Sarl | Low-oil pharmaceutical emulsion compositions comprising progestogen |
-
2011
- 2011-04-22 TW TW100114105A patent/TW201138782A/zh unknown
- 2011-04-25 AR ARP110101417A patent/AR081542A1/es not_active Application Discontinuation
- 2011-04-25 US US13/093,612 patent/US8476252B2/en active Active
- 2011-04-25 US US13/093,608 patent/US8765149B2/en active Active
- 2011-04-26 EP EP14196653.1A patent/EP2857042B1/en active Active
- 2011-04-26 KR KR1020127030500A patent/KR101822680B1/ko active IP Right Grant
- 2011-04-26 CN CN2011800315010A patent/CN102946864A/zh active Pending
- 2011-04-26 EA EA201291108A patent/EA022460B1/ru unknown
- 2011-04-26 WO PCT/EP2011/056548 patent/WO2011134944A2/en active Application Filing
- 2011-04-26 GE GEAP201112903A patent/GEP20166457B/en unknown
- 2011-04-26 CN CN201180031551.9A patent/CN102946865B/zh active Active
- 2011-04-26 MY MYPI2012004715A patent/MY156858A/en unknown
- 2011-04-26 SG SG2012078994A patent/SG185025A1/en unknown
- 2011-04-26 BR BR112012027279-9A patent/BR112012027279B1/pt active IP Right Grant
- 2011-04-26 AU AU2011246527A patent/AU2011246527B2/en active Active
- 2011-04-26 ES ES11716893.0T patent/ES2514690T3/es active Active
- 2011-04-26 CA CA2797253A patent/CA2797253C/en active Active
- 2011-04-26 ES ES14196653.1T patent/ES2606585T3/es active Active
- 2011-04-26 CA CA2797141A patent/CA2797141C/en active Active
- 2011-04-26 ES ES11717561.2T patent/ES2531646T3/es active Active
- 2011-04-26 EP EP11716893.0A patent/EP2563334B1/en active Active
- 2011-04-26 MX MX2012012491A patent/MX2012012491A/es active IP Right Grant
- 2011-04-26 EP EP11717561.2A patent/EP2563335B1/en active Active
- 2011-04-26 JP JP2013506625A patent/JP5886273B2/ja active Active
- 2011-04-26 WO PCT/EP2011/056539 patent/WO2011134937A2/en active Application Filing
- 2011-04-26 PT PT11717561T patent/PT2563335E/pt unknown
- 2011-04-26 EP EP14176970.3A patent/EP2801353B1/en active Active
- 2011-04-26 PL PL11717561T patent/PL2563335T3/pl unknown
- 2011-04-26 NZ NZ603176A patent/NZ603176A/en unknown
- 2011-04-26 ES ES14176970.3T patent/ES2576190T3/es active Active
-
2012
- 2012-10-25 IL IL222710A patent/IL222710A/en active IP Right Grant
- 2012-10-28 IL IL222738A patent/IL222738A/en active IP Right Grant
-
2013
- 2013-06-12 US US13/916,288 patent/US9572818B2/en active Active
- 2013-08-08 HK HK13109274.3A patent/HK1181998A1/xx unknown
-
2014
- 2014-05-16 US US14/279,834 patent/US20140335133A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012027279A2 (pt) | composições de emulsão farmacêutica com baixo teor de óleo que compreendem progestogênio | |
| SMT201600350B (it) | Composizioni farmaceutiche | |
| SMT201700008B (it) | Composizione farmaceutica | |
| BR112013020106A2 (pt) | composições de óleo | |
| DK2640893T4 (da) | Sammensætninger | |
| BR112014003052A2 (pt) | composições farmacêuticas | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| DK2395834T3 (da) | Natriumnitrit-holdige farmaceutiske sammensætninger | |
| BR112015003038A2 (pt) | composições lubrificantes | |
| CO6930367A2 (es) | Composiciones farmaceúticas | |
| BR112013025845A2 (pt) | formulações com viscosidade reduzida | |
| BR112013014826A2 (pt) | composição de gordura | |
| EE201300005A (et) | Ravimkoostis | |
| FR2968670B1 (fr) | Composition de graisse | |
| BR112013010756A2 (pt) | composição de óleo ou gordura | |
| IT1394400B1 (it) | Composizioni farmaceutiche | |
| CO7061076A2 (es) | Composición farmacéutica que contiene un derivado de dihidroquinazolina antiviralmente activo | |
| CO6801722A2 (es) | Composiciones farmacéuticas | |
| BR112012033194A2 (pt) | composição de fluído funcional | |
| BR112014009636A2 (pt) | composição dietética destinada à prevenção do risco cardiometabólico | |
| BR112013000356A2 (pt) | formulação farmacêutica injetável de malfalano | |
| SMT201600342B (it) | Composizioni farmaceutiche topiche comprendenti mometasone furoato | |
| ITTO20110268A1 (it) | Composizione di maquillage. | |
| BRPI1006076A2 (pt) | composicoes farmaceuticas | |
| CO6801717A2 (es) | Composiciones nasales de vitamina b12 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25G | Requested change of headquarter approved |
Owner name: BESINS HEALTHCARE LUXEMBOURG SARL (LU) |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/04/2011, OBSERVADAS AS CONDICOES LEGAIS. |